PepGen (PEPG) Profit After Tax (2021 - 2026)
PepGen (PEPG) reported Profit After Tax of -$17.8 million for Q1 2026, up 40.95% on a YoY basis from -$12.7 million in Q1 2025, and up 2.57% sequentially from -$18.3 million in Q4 2025.
PepGen (PEPG) Profit After Tax (2021 - 2026) Analysis & Trends
PepGen (PEPG) has 6 years of Profit After Tax data on file, last reported at -$17.8 million in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax rose 40.95% year-over-year to -$17.8 million; the trailing twelve-month figure through Mar 2026 stood at -$77.2 million (up 24.39% YoY), and the FY2025 full-year result was -$89.7 million, changed 0.36% from the prior year.
- Profit After Tax rose to -$17.8 million in Q1 2026, from -$18.3 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of -$14.9 million in Q4 2022 to a low of -$30.2 million in Q1 2025.
- A 5-year average of -$20.3 million and a median of -$18.6 million in 2022 frame the typical range for Profit After Tax.
- Across the five-year window, Profit After Tax plunged 221.3% in 2022 and surged 40.95% in 2026, its largest moves.
- Tracing PEPG's Profit After Tax over 5 years: stood at -$14.9 million in 2022, then dropped by 29.91% to -$19.4 million in 2023, then slipped by 14.68% to -$22.3 million in 2024, then gained by 17.75% to -$18.3 million in 2025, then grew by 2.57% to -$17.8 million in 2026.
- Business Quant data shows PEPG's Profit After Tax at -$17.8 million in Q1 2026, -$18.3 million in Q4 2025, and -$18.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | PepGen | 145.09 Mn | 145.09 Mn | - | -17.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.83 Mn |
| Dec 31, 2025 | -18.30 Mn |
| Sep 30, 2025 | -18.03 Mn |
| Jun 30, 2025 | -23.09 Mn |
| Mar 31, 2025 | -30.20 Mn |
| Dec 31, 2024 | -22.25 Mn |
| Sep 30, 2024 | -21.38 Mn |
| Jun 30, 2024 | -28.34 Mn |
| Mar 31, 2024 | -18.02 Mn |
| Dec 31, 2023 | -19.40 Mn |
| Sep 30, 2023 | -23.36 Mn |
| Jun 30, 2023 | -19.52 Mn |
| Mar 31, 2023 | -16.32 Mn |
| Dec 31, 2022 | -14.94 Mn |
| Sep 30, 2022 | -18.61 Mn |
| Jun 30, 2022 | -17.32 Mn |
| Mar 31, 2022 | -18.25 Mn |
| Dec 31, 2021 | -7.14 Mn |
| Sep 30, 2021 | -8.11 Mn |
| Jun 30, 2021 | -5.39 Mn |